E-LIB Suche - Ergebnisse für: Fléchon, A.

1

Pemigatinib for metastatic or surgically unresectable uroth..:

Necchi, A. ; Pouessel, D. ; Leibowitz, R....
Annals of Oncology. 35 (2024) 2 - p. 200-210 , 2024

Link: https://doi.org/10.1016/..

2

TROPHY-U-01, a phase II open-label study of sacituzumab gov..:

Loriot, Y. ; Petrylak, D.P. ; Rezazadeh Kalebasty, A....
Annals of Oncology. 35 (2024) 4 - p. 392-401 , 2024

Link: https://doi.org/10.1016/..

3

Analyse descriptive de la plus grande cohorte mondiale de p..:

Bailly, C. ; Barthelemy, P. ; Somme, F....
Médecine Nucléaire. 48 (2024) 2 - p. 55 , 2024

Link: https://doi.org/10.1016/..

4

Long term activity of vemurafenib in cancers with BRAF muta..:

Blay, J.Y. ; Cropet, C. ; Mansard, S....
ESMO Open. 8 (2023) 6 - p. 102038 , 2023

Link: https://doi.org/10.1016/..

5

Real life experience of compassionate use of 177Lu-PSMA-1 f..:

Paquet, E. ; Jung, M. ; Kryza, David...
Médecine Nucléaire. 47 (2023) 6 - p. 339-347 , 2023

Link: https://doi.org/10.1016/..

6

Urachal carcinoma: a large retrospective multicentric study..:

Guerin, M. ; Miran, C. ; Colomba, E....
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Retour d'expérience clinique de l'utilisation compassionnel..:

Paquet, E. ; Jung, M. ; Kryza, D....
Médecine Nucléaire. 47 (2023) 2 - p. 42-43 , 2023

Link: https://doi.org/10.1016/..

8

P1257: MOLECULAR CHARACTERIZATION AND CLONAL EVOLUTION OF M..:

Fléchon, L. ; Arib, I. ; Dutta, A....
HemaSphere. 6 (2022) - p. 1142-1143 , 2022

Link: https://doi.org/10.1097/..

9

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MUL..:

Hasan Bou Issa, L. ; Fléchon, L. ; Laine, W....
HemaSphere. 6 (2022) - p. 745-746 , 2022

Link: https://doi.org/10.1097/..

10

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P. ; Chabaud, S. ; Perol, D....
ESMO Open. 6 (2021) 1 - p. 100044 , 2021

Link: https://doi.org/10.1016/..

11

AcSé Nivolumab : résultats préliminaires pour le carcinome ..:

Toulemonde, E. ; Marabelle, A. ; Fléchon, A....
Annales de Dermatologie et de Vénéréologie. 147 (2020) 12 - p. A129 , 2020

Link: https://doi.org/10.1016/..

12

Design of a randomized controlled phase III study of dose d..:

Pfister, Christian ; Harter, Valentin ; Allory, Yves...
Contemporary Clinical Trials Communications. 17 (2020) - p. 100536 , 2020

Link: https://doi.org/10.1016/..

13

Randomized phase III trial of dose-dense MVAC or GC as peri..:

Pfister, C. ; Gravis, G. ; Flechon, A....
European Urology Open Science. 19 (2020) - p. e108-e109 , 2020

Link: https://doi.org/10.1016/..

14

Venous thromboembolic events stratified by number of risk f..:

Fankhauser, C. ; Tran, B. ; Ruiz-Morales, J.M....
European Urology Open Science. 19 (2020) - p. e398-e399 , 2020

Link: https://doi.org/10.1016/..

15

RETRACTED: Recommandations françaises du Comité de Cancérol..:

Savoie, P.-H. ; Fléchon, A. ; Morel-Journel, N....
Progrès en Urologie. 28 (2018) 12 - p. S131-S146 , 2018

Link: https://doi.org/10.1016/..